In vitro, JAKi treatment synergized with hyperinsulinemia to suppress differentiation of CD4+ cells by inhibiting transcription factors essential for lineage maturation, thereby facilitating senescent effector cell elimination. Here, CD4 is linked to hyperinsulinism.